Showing results (71-80 of 124) with videos related to
Sort By:
Pageof 13
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapseAndrew J Sakko, Miriam S Butler, Sharon Byers, et al.The Prostate|January 10, 2018
Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancerHui-Ming Lin, Brian Y Lee, Lesley Castillo, et al.Ebiomedicine|August 7, 2023
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotypeHeidi Fettke, Chao Dai, Edmond M Kwan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 9, 2013
Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinomaPo Yee Yip, Bing Yu, Wendy A Cooper, et al.Neoplasia (New York, N.Y.)|March 23, 2019
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic TargetRachel S Lee, Luxi Zhang, Adeline Berger, et al.The Prostate|March 28, 2024
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancerKate L Mahon, Sarah Im Sutherland, Hui Ming Lin, et al.Cancers|October 14, 2022
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by SimvastatinBlossom Mak, Hui-Ming Lin, Thy Duong, et al.Prostate Cancer and Prostatic Diseases|March 22, 2021
Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancerHui-Ming Lin, Kevin Huynh, Manish Kohli, et al.International Journal of Cancer|July 26, 2017
A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancerHui-Ming Lin, Kate L Mahon, Jacquelyn M Weir, et al.Ebiomedicine|December 9, 2025
Characterising the effect of circulating sphingolipids on metastatic prostate cancer cellsNeil Portman, Blossom Mak, Nicole Yeung, et al.Pageof 13